Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Nicke

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical and Experimental Medicine|November 7, 2023
Pan-PI3K inhibition with copanlisib overcomes Treg- and M2-TAM-mediated immune suppression and promotes anti-tumor immune responsesSimon Heller, Sarah Glaeske, Katja Gluske, et al.
Molecular Cell|December 13, 2005
Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cellsBarbara Nicke, Julie Bastien, Sophia J Khanna, et al.
Cancer Cell|December 11, 2007
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxelAhmed Ashour Ahmed, Anthony D Mills, Ashraf E K Ibrahim, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Chromosomal instability determines taxane responseCharles Swanton, Barbara Nicke, Marion Schuett, et al.
The Journal of Pathology|September 29, 2011
CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy inductionAlvin J X Lee, Rebecca Roylance, Jil Sander, et al.
Journal of Medicinal Chemistry|October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2ALars Wortmann, Nico Bräuer, Simon J Holton, et al.
Genome Medicine|August 13, 2010
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasetsCharles Swanton, James M Larkin, Marco Gerlinger, et al.
Journal of Medicinal Chemistry|December 20, 2018
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5Duy Nguyen, Clara Lemos, Lars Wortmann, et al.
Cell Chemical Biology|March 27, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signalingKeith Graham, Philip Lienau, Benjamin Bader, et al.
Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical and Experimental Medicine|November 7, 2023
Pan-PI3K inhibition with copanlisib overcomes Treg- and M2-TAM-mediated immune suppression and promotes anti-tumor immune responsesSimon Heller, Sarah Glaeske, Katja Gluske, et al.
Molecular Cell|December 13, 2005
Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cellsBarbara Nicke, Julie Bastien, Sophia J Khanna, et al.
Cancer Cell|December 11, 2007
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxelAhmed Ashour Ahmed, Anthony D Mills, Ashraf E K Ibrahim, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Chromosomal instability determines taxane responseCharles Swanton, Barbara Nicke, Marion Schuett, et al.
The Journal of Pathology|September 29, 2011
CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy inductionAlvin J X Lee, Rebecca Roylance, Jil Sander, et al.
Journal of Medicinal Chemistry|October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2ALars Wortmann, Nico Bräuer, Simon J Holton, et al.
Genome Medicine|August 13, 2010
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasetsCharles Swanton, James M Larkin, Marco Gerlinger, et al.
Journal of Medicinal Chemistry|December 20, 2018
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5Duy Nguyen, Clara Lemos, Lars Wortmann, et al.
Cell Chemical Biology|March 27, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signalingKeith Graham, Philip Lienau, Benjamin Bader, et al.
Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.
Pageof 2